JT Stratford LLC Invests $699,000 in Corteva, Inc. $CTVA

JT Stratford LLC purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA) in the third quarter, Holdings Channel.com reports. The fund purchased 10,338 shares of the company’s stock, valued at approximately $699,000.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Brighton Jones LLC raised its holdings in shares of Corteva by 307.2% in the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock valued at $888,000 after buying an additional 11,760 shares during the last quarter. Woodline Partners LP raised its position in Corteva by 40.3% in the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after purchasing an additional 16,644 shares during the last quarter. Ellevest Inc. increased its stake in shares of Corteva by 11.2% in the 2nd quarter. Ellevest Inc. now owns 5,414 shares of the company’s stock valued at $404,000 after buying an additional 544 shares during the period. Atlantic Union Bankshares Corp bought a new stake in shares of Corteva during the second quarter worth $1,386,000. Finally, Resona Asset Management Co. Ltd. lifted its stake in shares of Corteva by 3.9% during the second quarter. Resona Asset Management Co. Ltd. now owns 226,584 shares of the company’s stock valued at $16,883,000 after acquiring an additional 8,606 shares during the period. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of Corteva stock opened at $76.57 on Friday. The stock’s fifty day simple moving average is $72.81 and its 200 day simple moving average is $69.02. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $51.49 billion, a PE ratio of 48.46, a PEG ratio of 2.67 and a beta of 0.72. Corteva, Inc. has a 12 month low of $53.40 and a 12 month high of $80.90.

Corteva (NYSE:CTVA) last released its quarterly earnings data on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. The business had revenue of $3.91 billion for the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a return on equity of 9.06% and a net margin of 6.29%.Corteva’s revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.32 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts predict that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio (DPR) is presently 45.57%.

Analyst Upgrades and Downgrades

CTVA has been the subject of a number of research reports. BNP Paribas Exane lifted their price objective on Corteva from $70.00 to $72.00 and gave the stock a “neutral” rating in a research report on Monday, November 17th. Oppenheimer set a $86.00 price target on shares of Corteva in a research report on Thursday, February 5th. Citigroup increased their price objective on shares of Corteva from $74.00 to $80.00 and gave the company a “neutral” rating in a report on Thursday, February 5th. Argus raised shares of Corteva to a “strong-buy” rating in a report on Friday, January 16th. Finally, Rothschild & Co Redburn decreased their price objective on Corteva from $71.00 to $65.00 and set a “neutral” rating for the company in a research note on Tuesday, November 11th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $82.80.

Insiders Place Their Bets

In other Corteva news, insider Brian Titus sold 8,311 shares of the stock in a transaction dated Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider owned 8,090 shares in the company, valued at approximately $619,289.50. This represents a 50.67% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.14% of the company’s stock.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.